Literature DB >> 17350580

The XIST noncoding RNA functions independently of BRCA1 in X inactivation.

Cuiying Xiao1, Judith A Sharp, Misako Kawahara, Albert R Davalos, Michael J Difilippantonio, Ying Hu, Wenmei Li, Liu Cao, Ken Buetow, Thomas Ried, Brian P Chadwick, Chu-Xia Deng, Barbara Panning.   

Abstract

Females with germline mutations in BRCA1 are predisposed to develop breast and ovarian cancers. A previous report indicated that BRCA1 colocalizes with and is necessary for the correct localization of XIST, a noncoding RNA that coats the inactive X chromosome (Xi) to mediate formation of facultative heterochromatin. A model emerged from this study suggesting that loss of BRCA1 in female cells could reactivate genes on the Xi through loss of the XIST RNA. However, our independent studies of BRCA1 and XIST RNA revealed little evidence to support this model. We report that BRCA1 is not enriched on XIST RNA-coated chromatin of the Xi. Neither mutation nor depletion of BRCA1 causes significant changes in XIST RNA localization or X-linked gene expression. Together, these results do not support a role for BRCA1 in promoting XIST RNA localization to the Xi or regulating XIST-dependent functions in maintaining the stability of facultative heterochromatin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17350580     DOI: 10.1016/j.cell.2007.01.034

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  33 in total

Review 1.  The lesser known story of X chromosome reactivation: a closer look into the reprogramming of the inactive X chromosome.

Authors:  Eriona Hysolli; Yong Wook Jung; Yoshiaki Tanaka; Kun-Yong Kim; In-Hyun Park
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

Review 2.  Heterochromatin instability in cancer: from the Barr body to satellites and the nuclear periphery.

Authors:  Dawn M Carone; Jeanne B Lawrence
Journal:  Semin Cancer Biol       Date:  2012-06-18       Impact factor: 15.707

Review 3.  New twists in X-chromosome inactivation.

Authors:  Jennifer A Erwin; Jeannie T Lee
Journal:  Curr Opin Cell Biol       Date:  2008-05-26       Impact factor: 8.382

4.  Impact of intertumoral heterogeneity on predicting chemotherapy response of BRCA1-deficient mammary tumors.

Authors:  Sven Rottenberg; Marieke A Vollebergh; Bas de Hoon; Jorma de Ronde; Philip C Schouten; Ariena Kersbergen; Serge A L Zander; Marina Pajic; Janneke E Jaspers; Martijn Jonkers; Martin Lodén; Wendy Sol; Eline van der Burg; Jelle Wesseling; Jean-Pierre Gillet; Michael M Gottesman; Joost Gribnau; Lodewyk Wessels; Sabine C Linn; Jos Jonkers; Piet Borst
Journal:  Cancer Res       Date:  2012-03-06       Impact factor: 12.701

5.  Cohesin Removal Reprograms Gene Expression upon Mitotic Entry.

Authors:  Carlos Perea-Resa; Leah Bury; Iain M Cheeseman; Michael D Blower
Journal:  Mol Cell       Date:  2020-02-07       Impact factor: 17.970

Review 6.  Expression and function of a large non-coding RNA gene XIST in human cancer.

Authors:  Sarah M Weakley; Hao Wang; Qizhi Yao; Changyi Chen
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

Review 7.  The Ambivalent Role of lncRNA Xist in Carcinogenesis.

Authors:  Yung-Kang Chen; Yun Yen
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

8.  The histone chaperone Spt6 coordinates histone H3K27 demethylation and myogenesis.

Authors:  A Hongjun Wang; Hossein Zare; Kambiz Mousavi; Chaochen Wang; Cara E Moravec; Howard I Sirotkin; Kai Ge; Gustavo Gutierrez-Cruz; Vittorio Sartorelli
Journal:  EMBO J       Date:  2013-03-15       Impact factor: 11.598

9.  BRCA1 interacts with Smad3 and regulates Smad3-mediated TGF-beta signaling during oxidative stress responses.

Authors:  Huchun Li; Masayuki Sekine; Seyha Seng; Shalom Avraham; Hava Karsenty Avraham
Journal:  PLoS One       Date:  2009-09-21       Impact factor: 3.240

10.  Misbehaviour of XIST RNA in breast cancer cells.

Authors:  Silvia M Sirchia; Silvia Tabano; Laura Monti; Maria P Recalcati; Manuela Gariboldi; Francesca R Grati; Giovanni Porta; Palma Finelli; Paolo Radice; Monica Miozzo
Journal:  PLoS One       Date:  2009-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.